...
首页> 外文期刊>Biomacromolecules >Glucose-Responsive Vehicles Containing Phenylborate Ester for Controlled Insulin Release at Neutral pH
【24h】

Glucose-Responsive Vehicles Containing Phenylborate Ester for Controlled Insulin Release at Neutral pH

机译:含有苯硼酸酯的葡萄糖响应性载体可在中性pH下控制胰岛素的释放

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study is devoted to developing amphiphilic block polymers based on phenylborate ester, which can self-assemble to form nanoparticles, as a glucose-sensitive drug carrier. Poly(ethylene glycol)-nlock-poly[(2-phenyIboronic esters-1,3-dioxane-S-ethyl) methylacrylate] (MPEG5000-block-PBDEMA) was fabricated with MPEG5000-Br as a macroinitiator via atom transfer radical polymerization (ATRP). Using the solvent evaporation method, these block polymers can disperse in aqueous milieu to self-assemble into micellar aggregates with a spherical core-shell structure. Zeta potential and fluorescence techniques analysis showed a good purification effect, high encapsulation efficiency, and loading capacity of fluorescein isothiocyanate (FITC)-insulin-loaded polymeric micelles under optimal conditions. The in vitro insulin release profiles revealed definite glucose-responsive behavior of the polymeric micelles at pH 7.4 and 37 °C, depending on the environmental glucose concentration and the chemical composition of the block polymers. Further, circular dichroism spectroscopy demonstrated that the overall tertiary structure of the released insulin was in great agreement with standard insulin. ~1H NMR results of the polymeric micelles during glucose-responsive process supposed one possible insulin release mechanism via the polymer polarity transition from amphiphilic to double hydrophilic. The analysis of L929 mouse fibroblast cells viability suggested that the polymeric micelles from MPEGSOOO-block-PPBDEMA had low cell toxicity. The block polymers containing phenylborate ester that responded to changes in the glucose concentration at neutral pH are being aimed for use in self-regulated insulin delivery.
机译:这项研究致力于开发基于苯基硼酸酯的两亲嵌段聚合物,该聚合物可以自组装形成纳米颗粒,作为葡萄糖敏感的药物载体。以MPEG5000-Br为大分子引发剂,通过原子转移自由基聚合( ATRP)。使用溶剂蒸发法,这些嵌段聚合物可以分散在水溶液中,以自组装成具有球形核-壳结构的胶束聚集体。 Zeta电位和荧光技术分析表明,在最佳条件下,异硫氰酸荧光素(FITC)-胰岛素负载的聚合物胶束具有良好的纯化效果,较高的包封效率和负载能力。体外胰岛素释放曲线表明,取决于环境葡萄糖浓度和嵌段聚合物的化学组成,在pH 7.4和37°C下,聚合物胶束具有明确的葡萄糖响应行为。此外,圆二色性光谱表明,释放的胰岛素的整体三级结构与标准胰岛素高度吻合。葡萄糖响应过程中聚合物胶束的〜1H NMR结果推测是一种可能的胰岛素释放机制,其机理是聚合物极性从两亲性转变为双亲性。对L929小鼠成纤维细胞活力的分析表明,来自MPEGSOOO-block-PPBDEMA的聚合物胶束具有较低的细胞毒性。响应于中性pH下葡萄糖浓度变化的含苯硼酸酯的嵌段聚合物旨在用于自我调节的胰岛素输送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号